{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:20:22Z","timestamp":1790713222358,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.lungcan.2006.12.009","type":"journal-article","created":{"date-parts":[[2007,3,14]],"date-time":"2007-03-14T11:06:02Z","timestamp":1173870362000},"page":"229-234","source":"Crossref","is-referenced-by-count":164,"title":["FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer"],"prefix":"10.1016","volume":"56","author":[{"given":"David J.","family":"Hoopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Tann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Forquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Fen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon S.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"McGarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2006.12.009_bib1","series-title":"Cancer Facts and Figures 2005","author":"Society","year":"2005"},{"key":"10.1016\/j.lungcan.2006.12.009_bib2","series-title":"AJCC cancer staging manual","author":"Greene","year":"2002"},{"key":"10.1016\/j.lungcan.2006.12.009_bib3","doi-asserted-by":"crossref","first-page":"225S","DOI":"10.1378\/chest.89.4_Supplement.225S","article-title":"A new international staging system for lung cancer","volume":"89","author":"Mountain","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2006.12.009_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/1097-0142(19950901)76:5<787::AID-CNCR2820760512>3.0.CO;2-Q","article-title":"Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence","volume":"76","author":"Harpole","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2006.12.009_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0022-5223(19)39389-4","article-title":"Survival of patients surgically treated for stage I lung cancer","volume":"82","author":"Williams","year":"1981","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.lungcan.2006.12.009_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0022-5223(95)70427-2","article-title":"Incidence of local recurrence and second primary tumors in resected stage I lung cancer","volume":"109","author":"Martini","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.lungcan.2006.12.009_bib7","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1378\/chest.108.5.1278","article-title":"The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung","volume":"108","author":"Gauden","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2006.12.009_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<433::AID-CNCR2>3.0.CO;2-Q","article-title":"Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma: smaller volumes and higher doses\u2014a review","volume":"82","author":"Sibley","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2006.12.009_bib9","first-page":"489","article-title":"High-dose radiation therapy for inoperable non-small cell lung cancer without mediastinal involvement (clinical stage N0, N1)","volume":"172","author":"Hayakawa","year":"1996","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.lungcan.2006.12.009_bib10","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1378\/chest.124.5.1946","article-title":"Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer","volume":"124","author":"Timmerman","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2006.12.009_bib11","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ijrobp.2005.03.073","article-title":"Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study","volume":"63","author":"McGarry","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2006.12.009_bib12","doi-asserted-by":"crossref","first-page":"879","DOI":"10.7326\/0003-4819-139-11-200311180-00013","article-title":"Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis","volume":"139","author":"Gould","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lungcan.2006.12.009_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.lungcan.2006.12.009_bib14","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/cncr.20539","article-title":"Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study","volume":"101","author":"Onishi","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2006.12.009_bib15","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ijrobp.2005.05.034","article-title":"Clinical outcomes of a phase I\/II study of 48Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame","volume":"63","author":"Nagata","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2006.12.009_bib16","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0360-3016(01)01703-5","article-title":"Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience","volume":"51","author":"Uematsu","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2006.12.009_bib17","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/cncr.10853","article-title":"Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas","volume":"95","author":"Fukumoto","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2006.12.009_bib18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0360-3016(01)02731-6","article-title":"Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame","volume":"52","author":"Nagata","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2006.12.009_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0360-3016(02)04504-2","article-title":"Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC)","volume":"56","author":"Hof","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2006.12.009_bib20","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1200\/JCO.2005.06.129","article-title":"[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer","volume":"23","author":"Sasaki","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2006.12.009_bib21","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1200\/JCO.1999.17.10.3201","article-title":"Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group","volume":"17","author":"Vansteenkiste","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2006.12.009_bib22","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1200\/JCO.2004.11.109","article-title":"Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection","volume":"22","author":"Downey","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2006.12.009_bib23","first-page":"1519","article-title":"Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study","volume":"45","author":"Boellaard","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.lungcan.2006.12.009_bib24","first-page":"885","article-title":"Procedure guideline for tumor imaging with 18F-FDG PET\/CT 1.0","volume":"47","author":"Delbeke","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.lungcan.2006.12.009_bib25","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00259-003-1208-z","article-title":"The role of SPET and PET in monitoring tumour response to therapy","volume":"30","author":"Giannopoulou","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.lungcan.2006.12.009_bib26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00003072-199211000-00009","article-title":"Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer","volume":"17","author":"Kubota","year":"1992","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.lungcan.2006.12.009_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF00175162","article-title":"Evaluation of the treatment response of lung cancer with positron emission tomography and l-[methyl-11C]methionine: a preliminary study","volume":"20","author":"Kubota","year":"1993","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.lungcan.2006.12.009_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF03165392","article-title":"A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma","volume":"10","author":"Ichiya","year":"1996","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.lungcan.2006.12.009_bib29","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0360-3016(02)03038-9","article-title":"Dose\u2013response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer","volume":"54","author":"Choi","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2006.12.009_bib30","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.2003.07.054","article-title":"Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer","volume":"21","author":"Mac Manus","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2006.12.009_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijrobp.2004.06.146","article-title":"Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation","volume":"60","author":"Hicks","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2006.12.009_bib32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/BF02985960","article-title":"18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy","volume":"18","author":"Ishimori","year":"2004","journal-title":"Ann Nucl Med"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500206006453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500206006453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T21:15:51Z","timestamp":1587417351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500206006453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0169500206006453"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2006.12.009","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}